Your browser doesn't support javascript.
loading
A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.
Laajala, Teemu D; Sreekanth, Varsha; Soupir, Alex C; Creed, Jordan H; Halkola, Anni S; Calboli, Federico C F; Singaravelu, Kalaimathy; Orman, Michael V; Colin-Leitzinger, Christelle; Gerke, Travis; Fridley, Brooke L; Tyekucheva, Svitlana; Costello, James C.
Affiliation
  • Laajala TD; Department of Mathematics and Statistics, University of Turku, Turku, Finland. teelaa@utu.fi.
  • Sreekanth V; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. teelaa@utu.fi.
  • Soupir AC; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Creed JH; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Halkola AS; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Calboli FCF; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
  • Singaravelu K; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
  • Orman MV; Natural Resources Institute Finland (Luke), F-31600, Jokioinen, Finland.
  • Colin-Leitzinger C; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
  • Gerke T; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Fridley BL; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Tyekucheva S; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Costello JC; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Sci Data ; 10(1): 430, 2023 07 05.
Article in En | MEDLINE | ID: mdl-37407670
ABSTRACT
Genomic and transcriptomic data have been generated across a wide range of prostate cancer (PCa) study cohorts. These data can be used to better characterize the molecular features associated with clinical outcomes and to test hypotheses across multiple, independent patient cohorts. In addition, derived features, such as estimates of cell composition, risk scores, and androgen receptor (AR) scores, can be used to develop novel hypotheses leveraging existing multi-omic datasets. The full potential of such data is yet to be realized as independent datasets exist in different repositories, have been processed using different pipelines, and derived and clinical features are often not provided or  not standardized. Here, we present the curatedPCaData R package, a harmonized data resource representing >2900 primary tumor, >200 normal tissue, and >500 metastatic PCa samples across 19 datasets processed using standardized pipelines with updated gene annotations. We show that meta-analysis across harmonized studies has great potential for robust and clinically meaningful insights. curatedPCaData is an open and accessible community resource with code made available for reproducibility.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Systematic_reviews Limits: Humans / Male Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Systematic_reviews Limits: Humans / Male Language: En Year: 2023 Type: Article